More and deeper job cuts at St. Jude Medical - Bring Me The News

More and deeper job cuts at St. Jude Medical

The medical device maker plans another 500 job cuts, with about 100 of them in Minnesota. That follows an August round of layoffs that trimmed eighty jobs in the state. Sagging sales of defibrillators, pacemakers, and other heart rhythm devices have squeezed St. Jude and others in the industry.
Author:
Publish date:

The medical device maker plans another 500 job cuts, with about 100 of them in Minnesota. That follows an August round of layoffs that trimmed eighty jobs in the state. Sagging sales of defibrillators, pacemakers, and other heart rhythm devices have squeezed St. Jude and others in the industry.

Next Up

Related

St. Jude Medical to cut 300 jobs

St. Jude Medical Inc. said Thursday it is cutting 300 jobs as part of a corporate restructuring that the medical device company says will save it $50 million to $60 million annually starting next year, the Minneapolis St. Paul Business Journal reports.

Medtronic cutting 220 jobs in Mounds View

Medtronic is eliminating jobs at the Mounds View facility that makes heart rhythm devices. Sales of the company's pacemakers and implantable defibrillators have been sluggish for years.

Minneapolis cardiologist: St. Jude defibrillator leads still problematic

Design changes to a key Little Canada-based St. Jude Medical Inc. heart device, including an added layer of insulation to reduce the risk of abrasions, do not prevent defects that could lead to device failure and death. That's according to prominent cardiologist Robert Hauser of Abbott Northwestern Hospital in Minneapolis who made the comments in a study published in the medical journal Europace. He tells the Pioneer Press, "I can't say the Durata lead is bad. I just can't say that it's good."

Medtronic cutting 1,000 jobs despite growing profits

The Fridley-based medical device maker plans to eliminate positions in facilities around the globe, including 220 positions at its Mounds View-based division. Medtronic topped expectations in the fourth quarter, but continues to struggle with the sale of heart rhythm devices as well as devices used in spine surgery.

FDA approves new St. Jude Medical defibrillators

The Food and Drug Administration okayed the Little Canada-based company's Assura portfolio of implantable cardioverter defibrillators and cardiac resynchronization therapy devices. The new line is said to have "advanced sensing options designed to reduce the incidence of inappropriate shocks."